M&As

Lilly paid $2B upfront for vaccine biotechs; Infinimmune raises $75M

Endpoints News 10h ago $2B

Plus news about Tenax Therapeutics, Aureka Biotechnologies, ATyr Pharma, Prana Therapies and Mereo BioPharma. 💸 Lilly’s vaccine acquisitions: In May, Eli Lilly said it would pay up to $3.8 billion to acquire ...

Discussion

Sign in to join the discussion. Comments loading…